Millennium Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Millennium Capital Advisors's VRTX Position: Q3 2026 in Review
Millennium Capital Advisors opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 500 shares worth $261K. The stake represents 0.14% of the portfolio and ranks #116 among its holdings.
1,786 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Millennium Capital Advisors held 500 shares of Vertex Pharmaceuticals worth $261K as of Q3 2026.
- Vertex Pharmaceuticals was a new Millennium Capital Advisors position in Q3 2026.
- Vertex Pharmaceuticals made up 0.14% of Millennium Capital Advisors's portfolio in Q3 2026, its #116 holding.
- 1,786 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Millennium Capital Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.